These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 33097818)
1. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo. Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818 [TBL] [Abstract][Full Text] [Related]
2. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome. Jacob N; Jacobs JP; Kumagai K; Ha CWY; Kanazawa Y; Lagishetty V; Altmayer K; Hamill AM; Von Arx A; Sartor RB; Devkota S; Braun J; Michelsen KS; Targan SR; Shih DQ Mucosal Immunol; 2018 Sep; 11(5):1466-1476. PubMed ID: 29988118 [TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation. Siakavellas SI; Bamias G Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067 [TBL] [Abstract][Full Text] [Related]
4. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity. Valatas V; Kolios G; Bamias G Front Immunol; 2019; 10():583. PubMed ID: 30972074 [TBL] [Abstract][Full Text] [Related]
5. Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis. Sidhu-Varma M; Shih DQ; Targan SR Inflamm Bowel Dis; 2016 Mar; 22(3):548-59. PubMed ID: 26818423 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis. Shih DQ; Zheng L; Zhang X; Zhang H; Kanazawa Y; Ichikawa R; Wallace KL; Chen J; Pothoulakis C; Koon HW; Targan SR Mucosal Immunol; 2014 Nov; 7(6):1492-503. PubMed ID: 24850426 [TBL] [Abstract][Full Text] [Related]
7. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection. Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964 [TBL] [Abstract][Full Text] [Related]
8. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells. Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176 [TBL] [Abstract][Full Text] [Related]
9. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Meylan F; Richard AC; Siegel RM Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439 [TBL] [Abstract][Full Text] [Related]
10. Soluble TL1A is sufficient for activation of death receptor 3. Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650 [TBL] [Abstract][Full Text] [Related]
11. Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease. Perks WV; Singh RK; Jones GW; Twohig JP; Williams AS; Humphreys IR; Taylor PR; Jones SA; Wang ECY Am J Pathol; 2016 Nov; 186(11):2813-2823. PubMed ID: 27664471 [TBL] [Abstract][Full Text] [Related]
12. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation. Bamias G; Jia LG; Cominelli F Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723 [TBL] [Abstract][Full Text] [Related]
13. TL1A Promotes Fibrogenesis in Colonic Fibroblasts via the TGF-β1/Smad3 Signaling Pathway. Song J; Sun DL; Li CY; Luo YX; Liu Q; Yao Y; Zhang H; Yang TT; Song M; Bai XL; Zhang XL Curr Med Sci; 2024 Jun; 44(3):519-528. PubMed ID: 38842774 [TBL] [Abstract][Full Text] [Related]
14. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931 [TBL] [Abstract][Full Text] [Related]
15. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Barrett R; Zhang X; Koon HW; Vu M; Chang JY; Yeager N; Nguyen MA; Michelsen KS; Berel D; Pothoulakis C; Targan SR; Shih DQ Am J Pathol; 2012 Feb; 180(2):636-49. PubMed ID: 22138299 [TBL] [Abstract][Full Text] [Related]
16. TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice. Li H; Song J; Niu G; Zhang H; Guo J; Shih DQ; Targan SR; Zhang X Pathol Res Pract; 2018 Feb; 214(2):217-227. PubMed ID: 29254800 [TBL] [Abstract][Full Text] [Related]
17. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses. Wang X; Hu Y; Charpentier T; Lamarre A; Qi S; Wu J; Luo H J Immunol; 2013 Dec; 191(11):5420-9. PubMed ID: 24140642 [TBL] [Abstract][Full Text] [Related]
18. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030 [TBL] [Abstract][Full Text] [Related]
19. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma. Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596 [No Abstract] [Full Text] [Related]
20. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients. Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]